IL-1β pre-stimulation enhances the therapeutic effects of endometrial regenerative cells on experimental colitis
Open Access
- 5 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Stem Cell Research & Therapy
- Vol. 12 (1), 1-18
- https://doi.org/10.1186/s13287-021-02392-9
Abstract
Background: Ulcerative colitis (UC) is a chronic, relapsing, and non-specific inflammatory bowel disease, and the current treatment strategies were mainly used to relieve symptoms or for maintenance. Endometrial regenerative cells (ERCs) are mesenchymal-like stromal cells and have been demonstrated to alleviate multiple immune-dysregulation diseases. Pro-inflammatory stimuli were reported to enhance the immunosuppressive functions of ERCs, but the mechanism underlined is not fully understood. Here, we have designed this study to investigate the therapeutic effects of IL-1β-primed ERCs in the attenuation of experimental colitis. Methods: BALB/c mice were given 3% dextran sodium sulfate (DSS) for 7 consecutive days and free tap water for 3 days sequentially to induce experimental colitis. PBS (200 μL), ERCs, and IL-1β-primed ERCs (10ng/mL, 48 h) were injected (1 million/mouse/day, i.v.) on day 2, 5, and 8, respectively. Colonic and splenic samples were harvested on day 10 after DSS induction. Results: It was found that IL-1β-primed ERC treatment markedly attenuated colonic damage, body weight loss, and colon length shortening in colitis mice. Compared with other treatments, cell populations of CD4+IL-4+Th2 cells, CD4+CD25+FOXP3+ regulatory T cells (Tregs), and CD68+CD206+ macrophages in spleens were also significantly upregulated in the IL-1β-primed ERC-treated group (p < 0.05). In addition, lower expression of pro-inflammatory (IFN-γ, IL-17, TNF-α, and IL-6), but higher levels of anti-inflammatory cytokines (IL-4 and IL-10) were detected in colons in the IL-1β-primed ERC-treated group (p < 0.05 vs. other groups). Importantly, we also found that different generations of ERCs had an overall lower secretion of Dickkopf-1 (DKK1) by IL-1β pre-stimulation (p < 0.05) and a higher expression of β-catenin in colonic and splenic tissues after the administration of IL-1β-primed ERCs. Conclusions: This study has demonstrated that IL-1β pre-stimulation effectively downregulated DKK1 expression in ERCs, which in turn promoted the wnt/β-catenin pathway activation in colonic and splenic tissues. Consequently, IL-1β-primed ERCs exhibited an enhanced therapeutic effect in the attenuation of DSS-induced colitis.Keywords
Funding Information
- National Natural Science Foundation of China (No. 81273257, 81471584 and 82071802)
- Tianjin Application Basis and Cutting-Edge Technology Research Grant (No. 14JCZDJC35700)
- Li Jieshou Intestinal Barrier Research Special Fund (No. LJS_201412)
- Natural Science Foundation of Tianjin (No. 18JCZDJC35800)
- Tianjin Research Innovation Project for Postgraduate Students (No. 2019YJSS184)
This publication has 59 references indexed in Scilit:
- Therapeutic effects of a single injection of human umbilical mesenchymal stem cells on acute and chronic colitis in miceScientific Reports, 2019
- The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBDMucosal Immunology, 2016
- Mesenchymal Stem Cells Recruit Macrophages to Alleviate Experimental Colitis Through TGFβ1Cellular Physiology and Biochemistry, 2015
- Human Umbilical Cord-Derived Mesenchymal Stem Cells Downregulate Inflammatory Responses by Shifting the Treg/Th17 Profile in Experimental ColitisPharmacology, 2013
- Macrophage Activation and Polarization as an Adaptive Component of Innate ImmunityPublished by Elsevier BV ,2013
- Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitisCellular & Molecular Immunology, 2012
- Immunomodulatory Properties of Mesenchymal Stem Cells: Cytokines and FactorsAmerican Journal of Reproductive Immunology, 2011
- Cellular Mechanisms of TNF Function in Models of Inflammation and AutoimmunityPublished by S. Karger AG ,2010
- Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survivalEuropean Respiratory Journal, 2009
- Dendritic cells and the control of immunityNature, 1998